239 related articles for article (PubMed ID: 33320276)
1. Methotrexate Use for Patients with Psoriasis and Risk of Cutaneous Squamous Cell Carcinoma: A Nested Case-control Study.
Giannopoulos F; Gillstedt M; Laskowski M; Bruun Kristensen K; Polesie S
Acta Derm Venereol; 2021 Jan; 101(1):adv00365. PubMed ID: 33320276
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate treatment for patients with psoriasis and risk of cutaneous melanoma: a nested case-control study.
Polesie S; Gillstedt M; Paoli J; Osmancevic A
Br J Dermatol; 2020 Oct; 183(4):684-691. PubMed ID: 31981364
[TBL] [Abstract][Full Text] [Related]
3. Use of methotrexate and risk of skin cancer: a nationwide case-control study.
Polesie S; Gillstedt M; Schmidt SAJ; Egeberg A; Pottegård A; Kristensen K
Br J Cancer; 2023 Mar; 128(7):1311-1319. PubMed ID: 36739322
[TBL] [Abstract][Full Text] [Related]
4. Oral Squamous Cell Carcinoma Following Acute Methotrexate Toxicity in a Psoriasis Patient: A Causal Association or Mere Co-Incidence.
Choudhary R; Singh A; Chhabra N; Gupta AK
Curr Drug Saf; 2023; 18(4):580-583. PubMed ID: 36017826
[TBL] [Abstract][Full Text] [Related]
5. Non-Melanoma Skin Cancer Risk Among Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
deShazo R; Soltani-Arabshahi R; Krishnasamy S; Langley RG; Kalia S; Ståhle M; Langholff W; Goyal K; Fakharzadeh S; Galindo C; Srivastava B; Krueger G
J Drugs Dermatol; 2019 Oct; 18(10):1059-1060. PubMed ID: 31603636
[TBL] [Abstract][Full Text] [Related]
6. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
Marcil I; Stern RS
Lancet; 2001 Sep; 358(9287):1042-5. PubMed ID: 11589933
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancy.
Stern RS; Zierler S; Parrish JA
Cancer; 1982 Sep; 50(5):869-72. PubMed ID: 7093925
[TBL] [Abstract][Full Text] [Related]
8. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
Stern RS; Laird N
Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
Katz KA; Marcil I; Stern RS
J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
[TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden.
Raaschou P; Simard JF; Asker Hagelberg C; Askling J;
BMJ; 2016 Jan; 352():i262. PubMed ID: 26823527
[TBL] [Abstract][Full Text] [Related]
12. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population.
Asgari MM; Ray GT; Geier JL; Quesenberry CP
J Am Acad Dermatol; 2017 Apr; 76(4):632-638. PubMed ID: 28162854
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous ulceration with methotrexate.
Prescrire Int; 2003 Apr; 12(64):59-60. PubMed ID: 12674119
[TBL] [Abstract][Full Text] [Related]
14. Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis.
Sadoghi B; Kränke B; Cerroni L; Weger W
Acta Derm Venereol; 2021 Nov; 101(11):adv00593. PubMed ID: 34642767
[No Abstract] [Full Text] [Related]
15. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
Stern RS; Liebman EJ; Väkevä L
J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis, its treatment, and cancer in a cohort of Finnish patients.
Hannuksela-Svahn A; Pukkala E; Läärä E; Poikolainen K; Karvonen J
J Invest Dermatol; 2000 Mar; 114(3):587-90. PubMed ID: 10692122
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
[TBL] [Abstract][Full Text] [Related]
18. Treatments for psoriasis and the risk of malignancy.
Patel RV; Clark LN; Lebwohl M; Weinberg JM
J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
[TBL] [Abstract][Full Text] [Related]
19. [Metastasizing squamous cell carcinoma in patients with psoriasis treated with immunosuppressive agents].
Jensen DB; Albrektsen SB; Krag C
Ugeskr Laeger; 1989 Jul; 151(29):1884-5. PubMed ID: 2773104
[TBL] [Abstract][Full Text] [Related]
20. Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry.
Fiorentino D; Ho V; Lebwohl MG; Leite L; Hopkins L; Galindo C; Goyal K; Langholff W; Fakharzadeh S; Srivastava B; Langley RG
J Am Acad Dermatol; 2017 Nov; 77(5):845-854.e5. PubMed ID: 28893407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
